Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Over the last 12 months, insiders at Inari Medical, Inc. have bought $3M and sold $30.8M worth of Inari Medical, Inc. stock.
On average, over the past 5 years, insiders at Inari Medical, Inc. have bought $14.19M and sold $226.3M worth of stock each year.
Highest buying activity among insiders over the last 12 months: MILDER DONALD B (director) — $3M.
The last purchase of 2,100 shares for transaction amount of $112,303 was made by MILDER DONALD B (director) on 2023‑11‑08.
2024-06-21 | Sale | Chambers Rebecca | director | 260 0.0004% | $45.99 | $11,957 | -0.27% | |
2024-06-17 | Sale | Hoffman William | director | 40,000 0.063% | $43.54 | $1.74M | +6.36% | |
2024-06-12 | Sale | Hill, Mitch C. | Chief Financial Officer | 5,000 0.0086% | $47.60 | $237,977 | -2.23% | |
2024-05-28 | Sale | Hoffman William | director | 60,000 0.103% | $50.13 | $3.01M | -6.72% | |
2024-05-28 | Sale | Hykes Andrew | President and CEO | 3,000 0.0051% | $50.00 | $150,000 | -6.72% | |
2024-05-20 | Sale | Chambers Rebecca | director | 964 0.0016% | $45.39 | $43,756 | +3.01% | |
2024-05-16 | Sale | Hoffman William | director | 40,000 0.0685% | $46.60 | $1.86M | +1.87% | |
2024-05-13 | Sale | Hill, Mitch C. | Chief Financial Officer | 6,000 0.0104% | $45.97 | $275,812 | +2.87% | |
2024-05-01 | Sale | Hoffman William | director | 38,549 0.0671% | $42.00 | $1.62M | +10.89% | |
2024-04-16 | Sale | Hoffman William | director | 1,451 0.0026% | $40.00 | $58,040 | +17.01% | |
2024-04-12 | Sale | Hill, Mitch C. | Chief Financial Officer | 6,000 0.0104% | $40.96 | $245,760 | +11.95% | |
2024-03-18 | Sale | Hoffman William | director | 40,000 0.0682% | $41.13 | $1.65M | +9.00% | |
2024-03-12 | Sale | Hill, Mitch C. | Chief Financial Officer | 6,000 0.0104% | $41.91 | $251,461 | +8.01% | |
2023-12-15 | Sale | Hoffman William | director | 25,000 0.0433% | $65.08 | $1.63M | -27.97% | |
2023-12-12 | Sale | Hill, Mitch C. | Chief Financial Officer | 6,500 0.0112% | $62.75 | $407,855 | -24.67% | |
2023-11-16 | Sale | Hykes Andrew | President and CEO | 37,448 0.0656% | $59.82 | $2.24M | -15.94% | |
2023-11-16 | Sale | Tu Thomas | Chief Medical Officer | 25,451 0.0446% | $59.82 | $1.52M | -15.94% | |
2023-11-15 | Sale | Hoffman William | director | 25,000 0.0433% | $61.24 | $1.53M | -18.72% | |
2023-11-13 | Sale | Hill, Mitch C. | Chief Financial Officer | 6,500 0.0113% | $56.06 | $364,366 | -11.04% | |
2023-11-08 | MILDER DONALD B | director | 2,100 0.0037% | $53.48 | $112,303 | -4.53% |
MILDER DONALD B | director | 3031714 5.2643% | $46.49 | 3 | 24 | +71.74% |
Hoffman William | director | 825359 1.8154% | $46.49 | 1 | 57 | +71.74% |
Hykes Andrew | President and CEO | 465474 0.755% | $46.49 | 1 | 36 | +71.74% |
Tu Thomas | Chief Medical Officer | 320932 0.5573% | $46.49 | 1 | 26 | +71.74% |
Hill, Mitch C. | Chief Financial Officer | 181294 0.2956% | $46.49 | 1 | 42 | +71.74% |
Chambers Rebecca | director | 9684 0.0171% | $46.49 | 0 | 2 | |
Cooperatieve Gilde Healthcare IV U.A. | 10 percent owner | 4491679 7.7993% | $46.49 | 1 | 18 | +71.74% |
Nielsen Kirk G. | director | 46320 0.0804% | $46.49 | 0 | 1 | |
Presidio Management Group X LLC | 10 percent owner | 40883 0.071% | $46.49 | 1 | 1 | +71.74% |
Lucchese Cynthia L | director | 28091 0.0488% | $46.49 | 1 | 0 | +71.74% |
Szyman Catherine M. | director | 28091 0.0488% | $46.49 | 1 | 0 | +71.74% |
ROOT JONATHAN D | director | 335 0.0006% | $46.49 | 3 | 0 | +41.85% |
BlackRock | $406.98M | 14.59 | 8.48M | +26.67% | +$85.68M | 0.01 | |
The Vanguard Group | $268.68M | 9.63 | 5.6M | +11.15% | +$26.94M | 0.01 | |
Franklin Templeton Investments | $123.46M | 4.43 | 2.57M | -9.01% | -$12.23M | 0.04 | |
Millennium Management LLC | $111.03M | 3.98 | 2.31M | +319.39% | +$84.56M | 0.08 | |
AllianceBernstein | $106.22M | 3.81 | 2.21M | -6.97% | -$7.95M | 0.04 | |
State Street | $98.95M | 3.55 | 2.06M | +12.02% | +$10.62M | <0.01 | |
Brown Advisory | $87.5M | 3.14 | 1.82M | +7.15% | +$5.84M | 0.12 | |
Morgan Stanley | $75.5M | 2.71 | 1.57M | +99.96% | +$37.75M | 0.01 | |
Credit Suisse | $61.71M | 2.21 | 1.29M | +9.88% | +$5.55M | 0.06 | |
Wellington Management Company | $59.91M | 2.15 | 1.25M | -72.64% | -$159.04M | 0.01 | |
Geode Capital Management | $56.78M | 2.04 | 1.18M | +0.86% | +$484,955.61 | 0.01 | |
JPMorgan Chase | $54.73M | 1.96 | 1.14M | -30.66% | -$24.2M | 0.01 | |
Eventide Asset Management | $53.98M | 1.94 | 1.13M | +119.33% | +$29.37M | 0.85 | |
Voya Investment Management LLC | $41.13M | 1.48 | 857,259 | +10.86% | +$4.03M | 0.05 | |
Bamco | $37.29M | 1.34 | 777,152 | +27.37% | +$8.01M | 0.1 | |
American Century Investments | $37.11M | 1.33 | 773,432 | +49.72% | +$12.32M | 0.02 | |
Marshall Wace | $34.49M | 1.24 | 718,899 | +104.97% | +$17.66M | 0.04 | |
Dimensional Fund Advisors | $34.16M | 1.23 | 712,025 | +19.47% | +$5.57M | 0.01 | |
Point72 Asset Management | $33.33M | 1.2 | 694,592 | +3.91% | +$1.26M | 0.06 | |
Northern Trust | $28.36M | 1.02 | 590,989 | -8.34% | -$2.58M | 0.01 | |
Nuveen | $28.06M | 1.01 | 584,786 | -3.21% | -$930,380.17 | 0.01 | |
Fiera Capital | $27.67M | 0.99 | 576,724 | +3.88% | +$1.03M | 0.08 | |
Brown Capital Management | $25.07M | 0.9 | 522,422 | +4.21% | +$1.01M | 0.44 | |
Alger | $23.04M | 0.83 | 480,195 | +5.43% | +$1.19M | 0.11 | |
Barclays | $20.39M | 0.73 | 424,929 | +260.31% | +$14.73M | 0.01 | |
Slate Path Capital LP | $20.06M | 0.72 | 418,000 | 0% | +$0 | 0.4 | |
BNY Mellon | $19.89M | 0.71 | 414,460 | -14.49% | -$3.37M | <0.01 | |
Charles Schwab | $19.78M | 0.71 | 412,219 | +1.52% | +$296,804.29 | <0.01 | |
Point72 Europe London Llp | $19.54M | 0.7 | 407,235 | +22.59% | +$3.6M | 1.83 | |
Bank of America | $19.45M | 0.7 | 405,332 | +120.94% | +$10.65M | <0.01 | |
T. Rowe Price | $17.91M | 0.64 | 373,347 | +0.54% | +$96,108.29 | <0.01 | |
Balyasny Asset Management Llc | $17.66M | 0.63 | 367,988 | +100.06% | +$8.83M | 0.05 | |
JENNISON ASSOCIATES LLC | $16.48M | 0.59 | 343,439 | -22.56% | -$4.8M | 0.01 | |
Soleus Capital Management, L.P. | $13.29M | 0.48 | 277,000 | New | +$13.29M | 0.13 | |
Schonfeld Group | $12.45M | 0.45 | 259,424 | New | +$12.45M | 0.09 | |
Jacobs Levy Equity Management | $12.39M | 0.44 | 258,220 | +0.12% | +$14,298.04 | 0.06 | |
ClearBridge Investments | $11.98M | 0.43 | 249,618 | +41.17% | +$3.49M | 0.01 | |
New York State Common Retirement Fund | $11.95M | 0.43 | 248,984 | -20.05% | -$3M | 0.02 | |
Goldman Sachs | $11.59M | 0.42 | 241,618 | +33.01% | +$2.88M | <0.01 | |
Amundi | $9.16M | 0.41 | 236,954 | -3.55% | -$336,708.94 | <0.01 | |
Armistice Capital Llc | $10.69M | 0.38 | 222,751 | +380.88% | +$8.47M | 0.13 | |
Squarepoint Ops LLC | $10.55M | 0.38 | 219,815 | +22.85% | +$1.96M | 0.04 | |
First Light Asset Management | $10.26M | 0.37 | 213,940 | New | +$10.26M | 0.81 | |
Ameriprise Financial | $9.78M | 0.35 | 203,791 | +36.93% | +$2.64M | <0.01 | |
Integral Health Asset Management Llc | $9.6M | 0.34 | 200,000 | +100% | +$4.8M | 0.95 | |
ExodusPoint Capital Management, LP | $8.44M | 0.3 | 175,808 | +23.05% | +$1.58M | 0.11 | |
Affinity Asset Advisors | $8.4M | 0.3 | 175,000 | +775% | +$7.44M | 1.49 | |
RhumbLine Advisers | $7.25M | 0.26 | 151,121 | -7.21% | -$563,331.04 | 0.01 | |
Invesco | $6.91M | 0.25 | 144,091 | +145.2% | +$4.09M | <0.01 | |
Legal & General | $6.91M | 0.25 | 143,953 | +82.89% | +$3.13M | <0.01 |